These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. MR imaging of diffuse glioma. Yanaka K; Kamezaki T; Kobayashi E; Matsueda K; Yoshii Y; Nose T AJNR Am J Neuroradiol; 1992; 13(1):349-51. PubMed ID: 1595474 [TBL] [Abstract][Full Text] [Related]
8. In vivo magnetic resonance imaging and 31P spectroscopy of large human brain tumours at 1.5 tesla. Thomsen C; Jensen KE; Achten E; Henriksen O Acta Radiol; 1988; 29(1):77-82. PubMed ID: 2831923 [TBL] [Abstract][Full Text] [Related]
9. MR imaging of brain pilocytic astrocytoma: beyond the stereotype of benign astrocytoma. Gaudino S; Martucci M; Russo R; Visconti E; Gangemi E; D'Argento F; Verdolotti T; Lauriola L; Colosimo C Childs Nerv Syst; 2017 Jan; 33(1):35-54. PubMed ID: 27757570 [TBL] [Abstract][Full Text] [Related]
10. [MR imaging of intracranial tumors by superconducting system operating at 0.35 tesla]. Ochiai C No To Shinkei; 1985 May; 37(5):445-57. PubMed ID: 2992555 [No Abstract] [Full Text] [Related]
11. Nuclear magnetic resonance imaging of brain tumors unrevealed by CT. Gräfin von Einsiedel H; Löffler W Eur J Radiol; 1982 Aug; 2(3):226-34. PubMed ID: 7128609 [TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Discrepancy between Arterial Spin Labeling Images and Contrast-enhanced Images in the Diagnosis of Brain Tumors. Abe T; Mizobuchi Y; Sako W; Irahara S; Otomi Y; Obama Y; Nakajima K; Khashbat D; Majigsuren M; Kageji T; Nagahiro S; Harada M Magn Reson Med Sci; 2015; 14(4):313-9. PubMed ID: 26104074 [TBL] [Abstract][Full Text] [Related]
13. In vivo sodium-23 MRI in brain tumors: evaluation of preliminary clinical experience. Hashimoto T; Ikehira H; Fukuda H; Yamaura A; Watanabe O; Tateno Y; Tanaka R; Simon HE Am J Physiol Imaging; 1991; 6(2):74-80. PubMed ID: 1867865 [TBL] [Abstract][Full Text] [Related]
14. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. Floeth FW; Pauleit D; Wittsack HJ; Langen KJ; Reifenberger G; Hamacher K; Messing-Jünger M; Zilles K; Weber F; Stummer W; Steiger HJ; Woebker G; Müller HW; Coenen H; Sabel M J Neurosurg; 2005 Feb; 102(2):318-27. PubMed ID: 15739561 [TBL] [Abstract][Full Text] [Related]
15. Brain tumors: detection and typing by use of CPMG sequences and in vivo T2 measurements. Rinck PA; Meindl S; Higer HP; Bieler EU; Pfannenstiel P Radiology; 1985 Oct; 157(1):103-6. PubMed ID: 4034954 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy. She DJ; Xing Z; Zeng Z; Shang XY; Cao DR Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356 [TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy. Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039 [TBL] [Abstract][Full Text] [Related]
18. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Luyten PR; Marien AJ; Heindel W; van Gerwen PH; Herholz K; den Hollander JA; Friedmann G; Heiss WD Radiology; 1990 Sep; 176(3):791-9. PubMed ID: 2389038 [TBL] [Abstract][Full Text] [Related]
19. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations. Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883 [TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]